igra kumar screenshot 2015

Clinical Utility of CMV-specific IGRAs for Determining Protection Against CMV

This program is intended for physicians, surgeons, scientists, nurses, organ procurement personnel and other healthcare professionals interested in the clinical and research aspects of solid organ and tissue transplantation. At the end of this activity, participants should be able to determine the epidemiology and incidence of CMV infection in immunocompromised patients, discuss new data on the role IGRAs may play in the prediction of CMV infection, and describe the clinical value of IGRAs on pre-emptive or prophylaxis strategies for CMV.
Presented by:
  • Deepali Kumar, MD, MSc, FRCPC